DOACs plasma levels in relation to clinical outcome. How far have we come?
- PMID: 36906474
- DOI: 10.1016/j.thromres.2023.02.015
DOACs plasma levels in relation to clinical outcome. How far have we come?
Conflict of interest statement
Declaration of competing interest Dr. Huisman has received research support from Dutch Heart Foundation, Dutch Healthcare Fund, Boehringer Ingelheim, Bayer Health Care and Leo Pharma, all outside this work. Dr. Klok has received research support from Bayer, Bristol-Myers Squibb, Actelion, Boston Scientific, Leo Pharma, The Netherlands Organisation for Health Research and Development, The Dutch Thrombosis Association, The Dutch Heart Foundation and the Horizon Europe program, all outside this work and paid to his institution.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical